30
Oct
Oct
A recent urinary tract infection drug, Orlynvah, receives FDA approval, opening recent treatment options for patients with narrow or no alternative antimicrobial treatments. Urinary tract infection (UTI) is a common infection of the urinary tract, and almost half of people assigned female at birth (AFAB) will experience such an infection during their lifetime. Although UTIs […]